title: Expression and biological role of cytoglobin in human ovarian cancer.
abstract: Loss of cytoglobin is found to be involved in the progression of several human cancers. However, its expression pattern and biological roles in human ovarian cancers are not clear. In this study, we examined cytoglobin expression in 118 archived ovarian cancer specimens using immunohistochemistry. A total of 72 specimens (61.0 %) showed cytoglobin downregulation. cytoglobin downregulation positively correlated with advanced FIGO stage and tumor grade. Cytoglobin plasmid transfection was performed in SKOV3 cell line and siRNA knockdown was carried out in SW626 cell line. MTT, colony formation assay and matrigel invasion assay were carried out to assess the role of cytoglobin on cell proliferation and invasion. Cytoglobin overexpression inhibited cell growth, invasion, cell cycle progression and cyclin D1 expression in SKOV3 cell line and its depletion promoted cell proliferation, invasion, cell cycle transition and cyclin D1 expression. In conclusion, cytoglobin is downregulated in ovarian cancers and associated with advanced stage. Our data provides evidence that cytoglobin regulates the ovarian cancer cell proliferation and invasion.
authors.affiliation: Department of Gynaecology and Obstetrics, First Affiliated Hospital of China Medical University, 110001, Shenyang, Liaoning, China.
authors.forename: Haiying
authors.initials: H
authors.lastname: Chen
authors.forename: Xia
authors.initials: X
authors.lastname: Zhao
authors.forename: Tao
authors.initials: T
authors.lastname: Meng
mesh_terms: D000368:Aged; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000096:biosynthesis; D000078842:Cytoglobin; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005914:Globins / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000235:genetics*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D034741:RNA, Small Interfering
chemical_list: C530104:CCND1 protein, human; C000627265:CYGB protein, human; D000078842:Cytoglobin; D034741:RNA, Small Interfering; D019938:Cyclin D1; D005914:Globins
references.citation: Int J Oncol. 2012 Jun;40(6):1865-80
references.pmid: 22344671
references.citation: J Clin Oncol. 2003 Jun 1;21(11):2085-93
references.pmid: 12775733
references.citation: Mol Biol Evol. 2002 Apr;19(4):416-21
references.pmid: 11919282
references.citation: Clin Cancer Res. 2004 Aug 1;10(15):5168-77
references.pmid: 15297421
references.citation: Tumour Biol. 2012 Dec;33(6):2299-306
references.pmid: 22923389
references.citation: Cancer Res. 2008 Sep 15;68(18):7448-56
references.pmid: 18794132
references.citation: Respir Physiol Neurobiol. 2004 Dec 15;144(2-3):141-59
references.pmid: 15556098
references.citation: J Natl Cancer Inst. 2003 Mar 19;95(6):484-6
references.pmid: 12644542
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6422-30
references.pmid: 16166416
references.citation: BMC Cancer. 2013 May 20;13:247
references.pmid: 23688241
references.citation: Gynecol Oncol. 2010 Jun;117(3):429-39
references.pmid: 20233625
references.citation: Tumour Biol. 2013 Jun;34(3):1685-9
references.pmid: 23430585
references.citation: Br J Cancer. 1998;77(1):92-7
references.pmid: 9459151
references.citation: Hum Mol Genet. 2006 Jul 1;15(13):2038-44
references.pmid: 16698880
references.citation: Tumour Biol. 2014 Feb;35(2):1557-64
references.pmid: 24127040
references.citation: Br J Cancer. 2009 Jul 7;101(1):139-44
references.pmid: 19568272
references.citation: Oncogene. 2006 Mar 13;25(11):1620-8
references.pmid: 16550162
references.citation: Cancer Res. 2009 Aug 15;69(16):6565-72
references.pmid: 19638577
references.citation: Gynecol Oncol. 2010 May;117(2):358-65
references.pmid: 20207398
references.citation: Tumour Biol. 2014 Mar;35(3):1955-64
references.pmid: 24132590
references.citation: Radiat Res. 2011 Aug;176(2):198-207
references.pmid: 21631290
references.citation: Methods Mol Biol. 2009;472:413-37
references.pmid: 19107446
references.citation: Tumour Biol. 2013 Apr;34(2):1085-95
references.pmid: 23345014
references.citation: Mol Carcinog. 2005 Jul;43(3):141-54
references.pmid: 15937959
references.citation: CA Cancer J Clin. 2013 Jan;63(1):11-30
references.pmid: 23335087